Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00593385 · ClinicalTrials.gov registry record · NA
Atrium iCAST Iliac Stent Pivotal Study
A NA study, sponsored by Atrium Medical Corporation.
- Completed
- Registry status
- NA
- Development phase
- 165
- Enrollment target
NCT00593385 is a NA study that has completed, run by Atrium Medical Corporation. The registered enrollment target is 165 participants.
The verdict
NCT00593385, a NA study, has completed, sponsored by Atrium Medical Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 165 participants
- Enrollment target
Study Summary
Prospective, multicenter, non-randomized, single-arm registry to evaluate the safety and effectiveness of the iCAST Covered Stent System in the treatment of patients with symptomatic claudication or rest pain and angiographic confirmation of de novo or restenotic lesions in the common and/or external iliac artery.
Interventions
- DEVICE iCAST covered stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2007-10 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00593385
The ClinicalTrials.gov registry entry for NCT00593385 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Atrium Medical Corporation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iCAST covered stent is the first listed.
NCT00593385 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00593385 about?
NCT00593385 is a clinical study titled "Atrium iCAST Iliac Stent Pivotal Study". Prospective, multicenter, non-randomized, single-arm registry to evaluate the safety and effectiveness of the iCAST Covered Stent System in the treatment of patients with symptomatic claudication or rest pain and angiographic confirmation of de novo or restenotic lesions in the common and/or externa...
What is the current status of trial NCT00593385?
This trial is currently completed. It is a NA study. The enrollment target is 165 participants. The study started on 2007-10. Estimated completion is 2014-05.
What interventions are being tested in trial NCT00593385?
The interventions under investigation include: iCAST covered stent (DEVICE).
Who is sponsoring clinical trial NCT00593385?
This trial is sponsored by Atrium Medical Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.